Fertility-sparing treatment in endometrial carcinoma

n

Post category

Corresponding Author

European Society of Human Reproduction and Embryology

Publish date

02/06/2023
l

Comment count

A diagnosis of endometrial carcinoma in premenopausal women represents a challenge for clinicians. The standard surgical treatment for endometrial carcinoma consists of total hysterectomy with bilateral salpingo-oophorectomy, which effectively increases the chances of surviving the disease, however, devastatingly denies the woman the chance to carry a pregnancy. Fertility-sparing treatment can be a temporary option for these patients.

ESHRE, together with the European Society of Gynaecological Oncology (ESGO) and the European Society for Gynaecological Endoscopy (ESGE) have developed clinically relevant and evidence-based guidelines, focusing on key aspects of fertility-sparing treatment in order to improve the quality of care for women with endometrial carcinoma.

The multidisciplinary international group consisted of experts practising clinicians, researchers in the fields of gynaecological oncology, human reproduction, endoscopy and histopathology. The development group was chaired by Prof. Alexandros Rodolakis (ESGO, Greece), Dr. Kirsten Louise Tryde Macklon (ESHRE, Denmark) and Prof. Giovanni Scambia (ESGE, Italy).

The recommendations cover patients selection, tumour clinicopathological characteristics, treatment, and special issues.

The guideline is simultaneously published in the International Journal of Gynecological Cancer and Facts, Views and Vision in ObGyn.

View and download the guideline

Contact Us Today!

Nulla quis lorem ut libero malesuada feugiat. Sed porttitor lectus nibh. Sed porttitor lectus nibh. Curabitur non nulla sit amet.

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Ready for your next post?